来自瑞典索尔纳Aerocrine公司的一种名为NIOX VERO的设备,获得了FDA的批准在美国上市。该设备用于测量哮喘或潜在哮喘患者的呼出一氧化氮(FeNO)水平,并对其气道炎症进行评估。它通过彩色屏幕上的一款简单的游戏用来指导呼气,患者对其吹气10 s,1 min后即可显示结果。目前这是FDA批准的唯 A device called NIOX VERO from Sweden’s Solna Aerocrine acquired FDA approval for its listing in the United States. The device is used to measure the level of exhaled nitric oxide (FeNO) in asthmatic or potential asthmatic patients and to assess its airway inflammation. It uses a simple game on a color screen to instruct expiration, which the patient inflates for 10 s and displays the result in 1 min. This is the only FDA approved